New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder

Patients adherent to SUBLOCADE® for 12 months had 42% lower adjusted non-MOUD medical costs vs. those adherent to other forms of MOUDPatients ...
Portland Press Herald

UNE launching effort to train medical workers on addiction treatment for rural Mainers

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...
Morningstar

New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations

Both monthly maintenance doses (100 mg and 300 mg) improved opioid abstinence and were well-tolerated with no new safety signals identified. Post-hoc analyses indicated the 300-mg monthly maintenance ...
Hoodline

Inside San Jose Hospital’s Quiet War To Free Fentanyl-Hooked Teens

Inside the pediatric unit at Santa Clara Valley Medical Center, staff are not just treating broken bones and asthma attacks. They are running a hospital-based program that stabilizes teens and young ...
Pilot News

With Its Focus on Integrated Health Care, Lowering Recidivism and Data Analytics, Armor Health expands MAT and OTP programs for Franklin County, Ohio.

COLUMBUS, Ohio, Dec. 3, 2025 /PRNewswire/ -- Armor Health (ArmorHealthcare.com) Armor Health has enhanced its Medication-Assisted Treatment (MAT) and Opioid Treatment Program (OTP) in collaboration ...
WDTN

Indivior Presents New Real-World Evidence at AMCP Nexus 2025 Demonstrating Clinical and Economic Benefits of Adherence to Monthly Injectable Buprenorphine

Medicaid and commercially insured patients with high adherence to SUBLOCADE® experienced lower relapse rates and reduced healthcare resource utilization Adherence to SUBLOCADE was associated with ...